Estadístiques de PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion
Visites totals
| views | |
|---|---|
| PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: summary of an expert round-table discussion | 100 |
Visites totals per mes
| views | |
|---|---|
| May 2025 | 1 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 1 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| peg-fuo-pdlt.pdf | 116 |
| peg-fuo-pdlt.pdf(legacy) | 65 |
Vistes principals per país
| views | |
|---|---|
| United States | 67 |
| Spain | 10 |
| India | 7 |
| Germany | 4 |
| Belgium | 3 |
| Sweden | 3 |
| Ukraine | 2 |
| Australia | 1 |
| Czechia | 1 |
| Malaysia | 1 |
Visites principals per ciutat
| views | |
|---|---|
| San Ramon | 25 |
| Menlo Park | 10 |
| Mountain View | 7 |
| Barcelona | 6 |
| Noida | 6 |
| Fairfield | 4 |
| Ashburn | 3 |
| Boardman | 3 |
| Provo | 2 |
| San Diego | 2 |
| Ann Arbor | 1 |
| Cupertino | 1 |
| Córdoba | 1 |
| Mumbai | 1 |
| Otxandio | 1 |
| Petaling Jaya | 1 |
| Philadelphia | 1 |
| Pinjarra | 1 |
| Stockholm | 1 |